BioWorld - Wednesday, January 28, 2026

BioWorld Science

Jan. 27, 2016

View Archived Issues

Novo Nordisk announces the launch of Tresiba in the U.S.

Read More

A new patent listed and additional orphan drug designation granted for Procysbi in the U.S.

Read More

Factor VII deficiency corrected with gene therapy in large animal model

Read More

OncoTherapy begins phase Ib trials of peptide vaccine for malignant mesothelioma

Read More

Cleveland BioLabs starts a phase II trial of CBLB-612 in the Russian Federation

Read More

Novavax announces proposed offering of USD 200 million convertible senior notes

Read More

CE Mark for Quidel's Sofia S. pneumoniae Fluorescent Immunoassay

Read More

Faron Pharmaceuticals listed in London Stock Exchange AIM market

Read More

Living Cell Technologies reports findings from phase I/IIa study of NTCell for Parkinson's disease

Read More

FDA approves Dako's PD-L1 IHC 28-8 pharmDx test for use in melanoma

Read More

FDA clearance for ChloraDerm antimicrobial film dressing

Read More

CMV vaccine is safe and effective in stem cell transplant patients

Read More

Study unveils the potential of exosomes as therapeutic agents and delivery system for gene therapies

Read More

Ferring Pharmaceuticals and Karolinska Institutet to establish human microbiome research center

Read More

Afatinib demonstrates superiority to gefitinib on PFS in LUX-Lung 7 trial

Read More

Johnson & Johnson reflects on highlights of fourth quarter 2015

Read More

University of Texas System patents mitochondrial GLS1 inhibitors

Read More

Transplanted pancreatic beta-like cells exhibited glucose-stimulated insulin secretion in mice

Read More

FDA puts Medivation's pidilizumab on clinical hold

Read More

BBI-608 plus paclitaxel shows promise for the treatment of refractory pancreatic cancer

Read More

Prima BioMed starts phase I study of IMP-321 for the treatment of melanoma

Read More